Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Shares Repurchased (2022 - 2025)

Health Catalyst's Shares Repurchased history spans 3 years, with the latest figure at $5.0 million for Q1 2025.

  • For Q1 2025, Shares Repurchased changed N/A year-over-year to $5.0 million; the TTM value through Dec 2025 reached $5.0 million, changed N/A, while the annual FY2025 figure was $5.0 million, N/A changed from the prior year.
  • Shares Repurchased reached $5.0 million in Q1 2025 per HCAT's latest filing, up from $1.8 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $8.4 million in Q3 2022 to a low of $1.8 million in Q1 2023.
  • Average Shares Repurchased over 3 years is $5.1 million, with a median of $5.0 million recorded in 2025.